Log In
BCIQ
Print this Print this
 

RIP1 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Denali Therapeutics Inc.
DescriptionReceptor-interacting serine-threonine kinase 1 (RIPK1; RIP1) inhibitor
Molecular Target Receptor-interacting serine-threonine kinase 1 (RIPK1) (RIP1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today